LidoCream 5

Product NDC: 52763-501
11-digit product format: 527630501
Labeler code: 52763
Product ID: 52763-501_fa1db399-3bd1-456f-bcf5-9b97713ee5f1
Type: HUMAN OTC DRUG
Nonproprietary name: Lidocaine
Dosage form: CREAM
Route: TOPICAL
Labeler: Golden Touch LLC
Application: part346
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2010-12-01
Marketing end: 0000-00-00
Substance: LIDOCAINE
Active strength: 5 g/100g
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 8 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	52763-501		I	Inactivated by FDA	2026-10-15
excluded product	product	52763-501		D	Discontinued by firm	2026-10-15
excluded product	product	52763-501		I	Inactivated by FDA	2026-10-15
excluded product	product	52763-501		I	Inactivated by FDA	2026-10-15
excluded package	package	52763-501	52763-501-30	I	Inactivated by FDA	2026-10-15
excluded package	package	52763-501	52763-501-25	D	Discontinued by firm	2026-10-15
excluded package	package	52763-501	52763-501-60	I	Inactivated by FDA	2026-10-15
excluded package	package	52763-501	52763-501-12	I	Inactivated by FDA	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 3 · 156 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52763-501-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52763-501-25	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52763-501-60	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	52763-501-12	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52763-501-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52763-501-25	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52763-501-60	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	52763-501-12	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52763-501-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52763-501-25	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52763-501-60	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	52763-501-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52763-501-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52763-501-25	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52763-501-60	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	52763-501-12	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52763-501-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52763-501-25	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52763-501-60	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	52763-501-12	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52763-501-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52763-501-25	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52763-501-60	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	52763-501-12	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52763-501-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52763-501-25	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52763-501-60	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	52763-501-12	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
52763-501-12	2020-01-31	C162847	48780-1	9d75b9d0-7f9c-f424-e053-dadaa90a57ce	LidoCream 5
52763-501-30	2020-01-31	C162847	48780-1	9d75b9d0-5311-f424-e053-dadaa90a57ce	LidoCream 5
52763-501-60	2020-01-31	C162847	48780-1	9d75b9d0-7fa5-f424-e053-dadaa90a57ce	LidoCream 5

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
52763-501-12	LidoCream 5	120 g in 1 JAR	CREAM	120	2
52763-501-30	LidoCream 5	1 in 1 CARTON	CREAM	1	2
52763-501-30	LidoCream 5	30 g in 1 TUBE	CREAM	30	2
52763-501-60	LidoCream 5	60 g in 1 TUBE	CREAM	60	2
52763-501-60	LidoCream 5	1 in 1 CARTON	CREAM	1	2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LIDOCAINE	ACTIVE INGREDIENT	98PI200987	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
LIDOCAINE	ACTIVE INGREDIENT	98PI200987	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
LIDOCAINE	ACTIVE INGREDIENT	98PI200987	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
LIDOCAINE	ACTIVE MOIETY	98PI200987	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	4Q93RCW27E	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	4Q93RCW27E	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)	INACTIVE INGREDIENT	4Q93RCW27E	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
GLYCERYL OLEATE	INACTIVE INGREDIENT	4PC054V79P	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
GLYCERYL OLEATE	INACTIVE INGREDIENT	4PC054V79P	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
GLYCERYL OLEATE	INACTIVE INGREDIENT	4PC054V79P	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
SIMMONDSIA CHINENSIS SEED	INACTIVE INGREDIENT	D24K2Q1F6H	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
SIMMONDSIA CHINENSIS SEED	INACTIVE INGREDIENT	D24K2Q1F6H	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
SIMMONDSIA CHINENSIS SEED	INACTIVE INGREDIENT	D24K2Q1F6H	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52763-501	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2	Legacy NDC, 2 package rows	20151118_b0b5c3a8-11c5-4a29-91e9-ce86416ca919.zip
52763-501	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2	Legacy NDC, 2 package rows	20151113_99c752a4-1fec-452f-85ea-fcb5eabfe80d.zip
52763-501	LIDOCREAM 5 (LIDOCAINE) CREAM [GOLDEN TOUCH LLC]	2	Legacy NDC, 1 package rows	20151113_cc096fbb-84be-4b9d-8f3a-b3ae85951e95.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
98PI200987	LIDOCAINE	137-58-6	LIDOCAINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1534792	lidocaine 5 % Topical Cream	PSN	99c752a4-1fec-452f-85ea-fcb5eabfe80d	2
1534792	lidocaine 5 % Topical Cream	PSN	cc096fbb-84be-4b9d-8f3a-b3ae85951e95	2
1534792	lidocaine 5 % Topical Cream	PSN	b0b5c3a8-11c5-4a29-91e9-ce86416ca919	2
1544065	LidoCream5 5 % Topical Cream	PSN	99c752a4-1fec-452f-85ea-fcb5eabfe80d	2
1544065	LidoCream5 5 % Topical Cream	PSN	cc096fbb-84be-4b9d-8f3a-b3ae85951e95	2
1544065	LidoCream5 5 % Topical Cream	PSN	b0b5c3a8-11c5-4a29-91e9-ce86416ca919	2
1544065	lidocaine 50 MG/ML Topical Cream [Lidocream]	SBD	99c752a4-1fec-452f-85ea-fcb5eabfe80d	2
1544065	lidocaine 50 MG/ML Topical Cream [Lidocream]	SBD	cc096fbb-84be-4b9d-8f3a-b3ae85951e95	2
1544065	lidocaine 50 MG/ML Topical Cream [Lidocream]	SBD	b0b5c3a8-11c5-4a29-91e9-ce86416ca919	2
1534792	lidocaine 50 MG/ML Topical Cream	SCD	99c752a4-1fec-452f-85ea-fcb5eabfe80d	2
1534792	lidocaine 50 MG/ML Topical Cream	SCD	cc096fbb-84be-4b9d-8f3a-b3ae85951e95	2
1534792	lidocaine 50 MG/ML Topical Cream	SCD	b0b5c3a8-11c5-4a29-91e9-ce86416ca919	2
1534792	lidocaine 5 % Topical Cream	SY	b0b5c3a8-11c5-4a29-91e9-ce86416ca919	2
1534792	lidocaine 5 % Topical Cream	SY	cc096fbb-84be-4b9d-8f3a-b3ae85951e95	2
1534792	lidocaine 5 % Topical Cream	SY	99c752a4-1fec-452f-85ea-fcb5eabfe80d	2
1544065	Lidocream 5 % Topical Cream	SY	cc096fbb-84be-4b9d-8f3a-b3ae85951e95	2
1544065	Lidocream 5 % Topical Cream	SY	b0b5c3a8-11c5-4a29-91e9-ce86416ca919	2
1544065	Lidocream 5 % Topical Cream	SY	99c752a4-1fec-452f-85ea-fcb5eabfe80d	2
1544065	Lidocream 50 MG/ML Topical Cream	SY	cc096fbb-84be-4b9d-8f3a-b3ae85951e95	2
1544065	Lidocream 50 MG/ML Topical Cream	SY	99c752a4-1fec-452f-85ea-fcb5eabfe80d	2
1544065	Lidocream 50 MG/ML Topical Cream	SY	b0b5c3a8-11c5-4a29-91e9-ce86416ca919	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
52763-501-12	52763050112	120 g in 1 JAR	120 g	Historical
52763-501-30	52763050130	1 in 1 CARTON		Historical
52763-501-60	52763050160	60 g in 1 TUBE	60 g	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LidoCream 5	Golden Touch LLC	2015-11-11	HUMAN OTC DRUG LABEL	2
LidoCream 5	Golden Touch LLC	2015-11-11	HUMAN OTC DRUG LABEL	2
LidoCream 5	Golden Touch LLC	2015-11-11	HUMAN OTC DRUG LABEL	2